Carregant...
Sacubitril/Valsartan in Asian Patients with Heart Failure with Reduced Ejection Fraction
The Prospective comparison of Angiotensin Receptor-neprilysin inhibitor (ARNI) with Angiotensin converting enzyme inhibitor (ACEI) to Determine Impact on Global Mortality and morbidity in Heart Failure (HF) trial (PARADIGM-HF) showed that adding a neprilysin inhibitor (sacubitril) to a renin-angiote...
Guardat en:
| Publicat a: | Korean Circ J |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
The Korean Society of Cardiology
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6554586/ https://ncbi.nlm.nih.gov/pubmed/31172710 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4070/kcj.2019.0136 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|